Cyclo Therapeutics, Inc. (CYTHW)

USD 0.08

(-42.31%)

Market Cap (In USD)

11.12 Million

Revenue (In USD)

1.07 Million

Net Income (In USD)

-20.05 Million

Avg. Volume

379.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.05-0.33
PE
-
EPS
-
Beta Value
-0.381
ISIN
US23254X1101
CUSIP
23254X110
CIK
922247
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. N. Scott Fine
Employee Count
-
Website
http://www.cyclotherapeutics.com
Ipo Date
2020-12-18
Details
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.